Bir Yıl Sonunda Şehirde Yaşayan Türk Kadınındaki Human Papilloma Virus Persistans ve Klereansı

Year 2012, Volume: 25 Issue: 1, 10 - 16, 25.02.2015

Tevfik Yoldemir Funda Eren Mithat Erenus

Abstract

Amaç: Marmara Üniversitesi Hastanesi kadın hastalıkları polikliniğinde human papilloma virüs (HPV) pozitif saptanan kadınlarda değişik HPV genotiplerinin persistansını değerlendirmek.

Hastalar ve Yöntem: İlk prevalans çalışmasında HPV DNA testi pozitif saptanan 79 kadından 40'ı bir yıl sonra tekrar değerlendirildi. HPV tipleri polymerase chain reaction (PCR) ve mikroarray hibridizasyon teknikleri ile tanımlandı.

Bulgular: İlk değerlendirmenin bir yıl sonrasında kadınların %52,5'nin HPV enfeksiyonunun ortadan kalktığı; %35 ‘inin yeni bir HPV enfeksiyonu edindiği saptandı. 40 kadının %17,5'inde HPV DNA persistansı saptandı. Dokuz kadın aynı filogenetik ağaçtan HPV genotipi edinmişti. Yüksek riskli (YR) HPV tipi enfeksiyonun %43,33'ü ve düşük riskli (DR) HPV tipi enfeksiyonun %80'i ortadan kalkmıştı.

Sonuç: Yüksek riskli HPV tipleri saptanan kadınlarda persistans oranı artmıştı. Çok sayıda ve karışık tipte HPV enfeksiyonları HPV genotipinin persistansında önemli etkiye sahiptir. (Marmara Üniversitesi Tıp Fakültesi Dergisi 2012;25:10-5)

Keywords

Servikal sitoloji, HPV genotipi, HPV persistansı, HPV kliransı

The Persistence and Clearance Rate of Human Papilloma Virus Genotypes in Urban Turkish Women after One Year

Abstract

Objective: To evaluate the persistence of the different human papillomavirus
(HPV) genotypes in women detected positive for HPV at Marmara University
Hospital gynecologic outpatient clinics.
Patients and Methods: Forty out of 79 women who had been tested
positive for HPV DNA in our initial prevalance study were re-assessed after
one year. HPV types were identified by polymerase chain reaction (PCR)
and hybridization using a microarray.
Results: One year after the initial assessment, 52.5% of the women had their
initial HPV infection resolved and 35% of the women had acquired another
HPV infection. The HPV DNA persistence was detected in 17.5% of the
40 women. Nine women had acquisition of HPV genotype by the same
phylogenetic clade. 43.33% of high risk (HR) HPV type and 80% of the low
risk (LR) HPV type infection had resolved.
Conclusions: The persistence rate was increased in women with HR HPV
types. Multiple and mixed HPV infections have an important impact on the
persistence of HPV genotype. (Marmara Medical Journal 2012;25:10-5)
Key Words: Cervical cytology, HPV genotype, HPV persistence, HPV clearance

Keywords

Cervical cytology, HPV genotype, HPV persistence, HPV clearance

References

• CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases.
• Atkinson W, Wolfe S, Hambrosky J, et al, eds. 11th ed. Washington,
• DC: Public Health Foundation; 2009.
• Baseman J, Koutsky L. The epidomiology of human papillomavirus
• infections. J Clin Virol 2005;32(Suppl 1):S16–24. doi
• 1016/j.jcv.2004.12.008
• Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of
• human papillomavirus types in cytologically normal women in the
• International Agency for Research on Cancer HPV prevalence surveys:
• a pooled analysis. Lancet 2005; 366: 991–8. doi 10.1016/S0140-
• (05)67069-9
• Eren F, Erenus M, Bas E, et al. Prevalence of HPV infection by cytologic
• diagnosis and HPV DNA extraction and prevalence of the HPV
• genotypes detected in urban Turkish women, Int J Gynecol Obstet
• ;109: 235-8. doi 10.1016/j.ijgo.2010.01.007
• Hildesheim A, Schiffman MH,Gravitt PE, et al. Persistence of typespecific
• human papillomavirus infection among cytologically normal
• women. J Infect Dis 1994;169:235–40.
• Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal
• papillomavirus infection in young women. N Engl J Med
• ;338:423–8. doi 10.1056/NEJM199802123380703
• Elfgren K, Kalantari M, Moberger B, et al. A population based five-year
• follow-up study of cervical human papillomavirus infection. Am J
• Obstet Gynecol 2000;183:561–7. doi 10.1067/mob.[phone]
• Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is
• a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;
• : 12–19. doi 10.1002/(SICI)1096-9896(199909)189:1<12::AIDPATH431>3.0.CO;2-F
• Bosch FX, Manos MM, Munoz N, et al. Prevalence of human
• papillomavirus in cervical cancer: a worldwide perspective.
• International biological study on cervical cancer (IBSCC study group).
• J Natl Cancer Inst 1995; 87:796–802.
• Marmara Medical Journal 2012;25:10-5
• Yoldemir et al. 14 The Increased Persistence Rate with High Risk HPV Types
• Rozendaal L, Walboomers JM, van der Linden JC, et al. PCR-based
• high-risk HPV test in cervical cancer screening gives objective risk
• assessment of women with cytomorphologically normal cervical
• smears. Int J Cancer 1996;68:766–9. doi 10.1002/(SICI)1097-
• (19961211)68:6<766::AID-IJC13>3.0.CO;2-Z
• Kjaer SK, van den Brule AJ, Paull G, et al. Type specific persistence of
• high risk human papillomavirus (HPV) as indicator of high grade
• cervical squamous intraepithelial lesions in young women:
• population based prospective follow up study. BMJ 2002;325:572–6.
• Wallin KL, Wiklund F, Angström T, et al. Type-specific persistence of
• human papillomavirus DNA before the development of invasive
• cervical cancer. N Engl J Med 1999;341:1633-8. doi
• 1056/NEJM199911253412201
• Remmink AJ, Walboomers JM, Helmerhorst TJ, et al. The presence of
• persistent high-risk HPV genotypes in dysplastic cervical lesions is
• associated with progressive disease: natural history up to 36 months.
• Int J Cancer 1995;61:306–11.
• Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human
• papillomavirus infection as a predictor of cervical intraepithelial
• neoplasia. JAMA 2001;286:3106–14.
• Einstein MH, Burk RD. Persistent human papillomavirus infection:
• definitions and clinical implications. Papillomavirus Report
• ;12:119 -23.
• Hinchliffe SA, VanVclzen D, Korporaal H, et al. Transience of cervical
• HPV infection in sexually active young women with normal
• cervicovaginal cylology. Br J Cancer 1995:72:943-5.
• Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus
• infection as a risk factor for persistent cervical dysplasia. J Natl Cancer
• lnst 1995:87:1365-71.
• Kirnbauer R, Booy F, Cheng N, et al. Papillomavirus L1 major capsid
• protein self-assembles into virus like particles that are highly
• immunogenic. Proc Natl Acad Sci USA 1992;89:80-4.
• Woodman CB, Collins S, Winter H, et al. Natural history of cervical
• human papillomavirus infection in young women: a longitudinal
• cohort study. Lancet 2001;357: 1831–6. doi 10.1016/S0140-
• (00)04956-4
• Molano M, Van den Brule A, Plummer M, et al. Determinants of
• clearance of human papillomavirus infections in Colombian women
• with normal cytology: a population-based, 5-year follow-up study.
• Am J Epidemiol 2003;158:486–94.
• Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and
• clearance of cervical human papillomavirus infection in women from
• a high-risk area for cervical cancer. J Infect Dis 1999;180:1415–23.
• doi 10.1086/315086
• Richardson H, Kelsall G, Tellier P, et al. The natural history of typespecific
• human papillomavirus infections in female university
• students. Cancer Epidemiol Biomarkers Prev 2003;12:485–90.
• Brisson J, Bairati I, Morin C, et al. Determinants of persistent detection
• of human papillomavirus DNA in the uterine cervix. J Infect Dis 1996;
• : 794–9.
• Thomas KK, Hughes JP, Kuypers JM, et al. Concurrent and sequential
• acquisition of different genital human papillomavirus types. J Infect
• Dis 2000;182:1097–102. doi 10.1086/315805
• Perrons C, Jelley R, Kleter B, et al. Detection of persistent high risk
• human papillomavirus infections with hybrid capture II and
• SPF10/LiPA. J Clin Virol 2005;32: 278–85. doi
• 1016/j.jcv.2004.08.009
• Liaw KL, Hildesheim A, Burk RD, et al. A prospective study of human
• papillomavirus (HPV) type 16 DNA detection by polymerase chain
• reaction and its association with acquisition and persistence of other
• HPV types. J Infect Dis 2001;183:8–15. doi 10.1086/317638
• Rousseau MC, Abrahamowicz M, Villa LL, et al. Predictors of cervical
• coinfection with multiple human papillomavirus types. Cancer
• Epidemiol Biomarkers Prev 2003;12:1029–37.
• Zielinski GD, Snijders PJF, Rozendaal L, et al. HPV presence precedes
• abnormal cytology in women developing cervical cancer and signals
• false negative smears Br J Cancer 2001; 85: 398–404. doi
• 1054/bjoc.2001.1926
• Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human
• papillomavirus and risk of CIN3 or cervical cancer. Lancet
• ;360:228–9. doi 10.1016/S0140-6736(02)09463-1
• Herrero R, Hildesheim A, Bratti C, et al. Population based study of
• human papillomavirus infection and cervical neoplasia in rural Costa
• Rica. J Natl Cancer Inst 2000;92:464–74.
• Hall S, Lorincz A, Shah F, et al. Human papillomavirus DNA detection
• in cervical specimens by hybrid capture: correlation with cytologic and
• histologic diagnoses of squamous intraepithelial lesions of the cervix.
• Gynecol Oncol 1996;62: 353–9. doi 10.1006/gyno.1996.0248
• Nindl I, Greinke C, Zahm DM, et al. Human papillomavirus distribution
• in cervical tissues of different morphology as determined by hybrid
• capture assay and PCR. Int J Gynecol Pathol 1997; 16: 197–204.
• Swan DC, Tucker RA, Tortolero-Luna G, et al. Human papillomavirus
• (HPV) DNA copy number is dependent on grade of cervical disease
• and HPV type. J Clin Microbiol 1999:37; 1030–4.
• Heard I, Tassie JM, Schmitz V, et al. Increased risk of cervical disease
• among human immunodeficiency virus-infected women with severe
• immunosuppression and high human papillomavirus load(1). Obstet
• Gynecol 2000;96: 403–9.
• Clavel C, Masure M, Levert M, et al. Human papillomavirus detection
• by the hybrid capture II assay: a reliable test to select women with
• normal cervical smears at risk for developing cervical lesions. Diagn
• Mol Pathol 2000;9:145–150.
• van Duin M, Snijders PJ, Schrijnemakers HF, et al. Human
• papillomavirus 16 load in normal and abnormal cervical scrapes: an
• indicator of CIN II/III and viral clearance. Int J Cancer 2002;98:590–5.
• Crum CP, Beach KJ, Hedley ML, et al. Dynamics of human
• papillomavirus infection between biopsy and excision of cervical
• intraepithelial neoplasia: results from the ZYC101a protocol. J Infect
• Dis 2004;189: 1348–54. doi 10.1086/382956
• Koshiol J, Lindsay L, Pimenta J M, et al. Persistent human papillomavirus
• infection and cervical neoplasia: A systematic review and meta-analysis.
• Am J Epidemiol 2008;168:123–37. doi 10.1093/aje/kwn036
• Kovacic MB, Castle PE., Herrero R, et al. Relationships of human
• papillomavirus type, qualitative viral load, and age with cytologic
• abnormality. Cancer Res 2006; 66: 10112-9. doi 10.1158/0008-
• CAN-06-1812
• Nielsen A, Kjaer SK, Munk C, Iftner T. Type-specific HPV infection and
• multiple HPV types: prevalence and risk factor profile in nearly 12000
• younger and older Danish women. Sex Transm Dis 2008;35:276–82.
• doi 10.1097/OLQ.0b013e31815ac5c7